GUSTO IIa
- 275 sites in 12 countries
- 2,564 participants
- 18 sites in New Zealand
- 227 sites globally
The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO) IIa Investigators. Randomized trial of intravenous heparin versus recombinant hirudin for acute coronary syndromes. At 275 participating hospitals in 12 countries, with enrollment of 2,564 patients.
